Sponsor or institution

Clinical trials and research at Partillion Bioscience Corporation

• 6NIH research projects

NIH-funded research (6)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Nanovial tools to map how single cells talk to each other at scale

  New technology to study how individual cells communicate and affect each other, using easy-to-use nanovial kits with common single-cell sequencing methods.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-11410488

• Accelerating antibody discovery using memory B cells

  A new program aims to speed up finding useful monoclonal antibodies by leveraging memory B cells with innovative tools to sort and test many cells at once.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-11310825

• Multiplexed antibody discovery using single-cell Nanovials

  A patient-friendly look at a new method to speed up creating monoclonal antibodies by analyzing individual antibody-secreting cells more efficiently.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-11185485

• Improving the discovery of effective antibody therapies

  This study is working on a faster and easier way to find important proteins called monoclonal antibodies, which help create better treatments for patients, so you can get more effective therapies more quickly and at a lower cost.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-11185382

• Exploring how antibody sequences work at the single-cell level using new technology

  This study is testing a new technology that helps scientists look closely at how individual antibodies work, which could lead to quicker and better treatments for diseases like autoimmune disorders and cancer, ultimately helping patients get the right therapies faster.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-10928715

• Using hydrogel microparticles to improve CAR-T cell therapies for cancer treatment

  This study is working on improving CAR-T cell therapies for cancer by using special technology to find the best CAR-T cells that can fight tumors, which could lead to better treatments for patients.

  NIH research Partillion Bioscience Corporation · Los Angeles, United States · NIH-10922670

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →